462 Studies Now Enrolling
PrecISE: Precision Interventions for Severe and/or Exacerbation - Prone Asthma
Precise: Precision Interventions for Severe Asthma
| Sponsor: | University of North Carolina at Chapel Hill and National Heart, Lung, and Blood Institute |
| Enrolling: | Male and Female Patients |
| Study Length: | 14 Months |
| Clinic Visits: | 14 |
| IRB Number: | AAAS8256 |
| U.S. Govt. ID: | NCT04129931 |
| Contact: | Jotti Saroya: 212-305-0251 / tks2127@cumc.columbia.edu |
Additional Study Information:
Precision medicine is an individual-based care, a new approach to care based on someone's medical history, where they live, and profile (age, gender, and so on). We will use precision medicine to understand treatments for severe asthma. These treatments are not yet used for asthma today. We have two goals for the PrecISE study: 1. Make it easier to identify different types of severe asthma. 2. Understand the best ways to treat these different types of severe asthma. The length of time you are in the study will range from 1 to 3.5 years, and it will depend on when you enroll.
Do You Qualify?
| Are you currently in another study? | Yes | No |
| Do you have diagnosed severe asthma and taking an asthma controller medication? | Yes | No |
| Are you available to do a study that lasts for about 14-32 months or longer? | Yes | No |
| Are you currently a smoker (cigarettes, vape e-cigs, etc.)? | Yes | No |
| Do you own a smartphone or tablet and would be willing to use it to download an app to use during the study? | Yes | No |